3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Head and Neck Neoplasms
4
Stomatitis
3
Squamous Cell Carcinoma of Head and Neck
3
Laryngeal Neoplasms
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Squamous Intraepithelial Lesions
2
Skin Neoplasms
2
Hematologic Neoplasms
2
Dyspareunia
2
Carcinoma, Hepatocellular
2
Carcinoma, Basal Cell
2
Warts
1
Vulvar Neoplasms
1
Vomiting
1
Vaginal Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Soft Tissue Neoplasms
1
Retinoblastoma
1
Radiodermatitis
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Papillomavirus Infections
1
Papilloma
1
Pain
1
Ovarian Neoplasms
1
Neoplasms
1
Interventions
Doxorubicin
20
Vincristine
17
Zidovudine
13
Cyclophosphamide
12
Bleomycin
12
Etoposide
10
Rituximab
6
Prednisone
6
Interferon alpha-2
6
Cytarabine
6
Liposomes
5
Filgrastim
5
Dexamethasone
5
tecogalan
4
sargramostim
4
Specimen Handling
4
Methotrexate
4
Magnetic Resonance Spectroscopy
4
Leucovorin
4
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
4
Fluorouracil
4
Biopsy
4
Peripheral Blood Stem Cell Transplantation
3
Paclitaxel
3
Nivolumab
3
interferon alfa-n1
2
fludarabine phosphate
2
fludarabine
2
cabozantinib
2
Whole-Body Irradiation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
HIV Infections
×
Laser Therapy
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts